Literature DB >> 16179429

Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation.

Dan Constantinescu1, Heather L Gray, Paul J Sammak, Gerald P Schatten, Antonei B Csoka.   

Abstract

Nuclear lamins comprise the nuclear lamina, a scaffold-like structure that lines the inner nuclear membrane. B-type lamins are present in almost all cell types, but A-type lamins are expressed predominantly in differentiated cells, suggesting a role in maintenance of the differentiated state. Previous studies have shown that lamin A/C is not expressed during mouse development before day 9, nor in undifferentiated mouse embryonic carcinoma cells. To further investigate the role of lamins in cell phenotype maintenance and differentiation, we examined lamin expression in undifferentiated mouse and human embryonic stem (ES) cells. Wide-field and confocal immunofluorescence microscopy and semiquantitative reverse transcription-polymerase chain reaction analysis revealed that undifferentiated mouse and human ES cells express lamins B1 and B2 but not lamin A/C. Mouse ES cells display high levels of lamins B1 and B2 localized both at the nuclear periphery and throughout the nucleoplasm, but in human ES cells, B1 and B2 expression is dimmer and localized primarily at the nuclear periphery. Lamin A/C expression is activated during human ES cell differentiation before downregulation of the pluripotency marker Oct-3/4 but not before the downregulation of the pluripotency markers Tra-1-60, Tra-1-81, and SSEA-4. Our results identify the absence of A-type lamin expression as a novel marker for undifferentiated ES cells and further support a role for nuclear lamins in cell maintenance and differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179429     DOI: 10.1634/stemcells.2004-0159

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  157 in total

1.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

Review 2.  Epigenetic landscape of pluripotent stem cells.

Authors:  Ji Woong Han; Young-sup Yoon
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

Review 3.  Lamins at a glance.

Authors:  Chin Yee Ho; Jan Lammerding
Journal:  J Cell Sci       Date:  2012-05-01       Impact factor: 5.285

Review 4.  Nuclear lamins.

Authors:  Thomas Dechat; Stephen A Adam; Pekka Taimen; Takeshi Shimi; Robert D Goldman
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-08       Impact factor: 10.005

Review 5.  Progeria syndromes and ageing: what is the connection?

Authors:  Christopher R Burtner; Brian K Kennedy
Journal:  Nat Rev Mol Cell Biol       Date:  2010-08       Impact factor: 94.444

Review 6.  Nuclear Mechanics and Stem Cell Differentiation.

Authors:  Xinjian Mao; Nuria Gavara; Guanbin Song
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

Review 7.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

8.  Nuclear lamins in cancer.

Authors:  Jerome Irianto; Charlotte R Pfeifer; Irena L Ivanovska; Joe Swift; Dennis E Discher
Journal:  Cell Mol Bioeng       Date:  2016-04-18       Impact factor: 2.321

9.  Square prism micropillars improve osteogenicity of poly(methyl methacrylate) surfaces.

Authors:  O Hasturk; M Ermis; U Demirci; N Hasirci; V Hasirci
Journal:  J Mater Sci Mater Med       Date:  2018-05-02       Impact factor: 3.896

10.  Nuclear Lamin Protein C Is Linked to Lineage-Specific, Whole-Cell Mechanical Properties.

Authors:  Rafael D González-Cruz; Jessica S Sadick; Vera C Fonseca; Eric M Darling
Journal:  Cell Mol Bioeng       Date:  2018-01-16       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.